ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000226310.1	Ponatinib	Bladder urothelial carcinoma	0.009271327	Sensitive
ENSG00000226310.1	Ponatinib	Pancreatic adenocarcinoma	0.038719865	Resistant